| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO | President, CEO and Chair | President & CEO
1 company
Curt R Hartman last filed a Form 4 in November 2024, as President and CEO at CNMD.
Our model assigns Curt R Hartman a middling insider score of 66/100, based on 7 past trades. Over a 12-month horizon, 85.7% of those trades were profitable, with an average 12-month return of +19.3%.
At the last filing, the largest reported position was 9,996 shares of CNMD. The CNMD filings lean toward selling, a net 79,847 shares.
Curt R Hartman has 27 Form 4 filings on record from January 2015 to November 2024, all as President and CEO at Conmed (CNMD), 2015–2024.
The 66 reported transactions were 16 option exercises, 14 open-market sales, 13 tax withholdings and 13 option or other derivative awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 3 purchases worth about $616K and 9 sales worth about $11.9M.
The largest open-market purchase was 8,030 shares of CNMD at an average $40.11 on March 10, 2017, about $322K.
The largest open-market sale was 42,347 shares of CNMD at an average $132.09 on June 3, 2021, about $5.6M. Twelve months later CNMD was down 16%.
Shares as reported in the last Form 4 for each company; the most recent is from November 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2023 | CNMD Conmed Corp | President, CEO and Chair | Sell | 1,000 | $136.00 | $136,000.00 | -18.9% | -21.2% | -47.9% | |
| Mar 14, 2023 | CNMD Conmed Corp | President, CEO and Chair | Sell | 5,000 | $92.81 | $464,028.50 | -48.5% | +39.9% | -7.9% | |
| Sep 15, 2022 | CNMD Conmed Corp | President, CEO and Chair | Sell | 3,500 | $93.94 | $328,776.00 | -25.4% | +0.6% | +16.5% | |
| Mar 15, 2022 | CNMD Conmed Corp | President, CEO and Chair | Sale+OE | 2,500 | $138.43 | $346,072.50 | -25.1% | -30.3% | -34.3% | |
| Sep 15, 2021 | CNMD Conmed Corp | President, CEO and Chair | Sale+OE | 2,500 | $127.39 | $318,467.50 | -3.7% | +4.5% | -27.3% | |
| Jun 3, 2021 | CNMD Conmed Corp | President, CEO and Chair | Sell | 42,347 | $132.09 | $5,593,488.19 | -38.6% | -3.1% | -16.2% | |
| May 14, 2021 | CNMD Conmed Corp | President, CEO and Chair | Sell | 13,030 | $142.87 | $1,861,535.50 | -10.6% | -13.0% | -18.0% | |
| Feb 18, 2021 | CNMD Conmed Corp | President, CEO and Chair | Sell | 15,000 | $119.93 | $1,798,895.00 | -10.9% | - | - | |
| Nov 30, 2020 | CNMD Conmed Corp | President, CEO and Chair | Sale+OE | 10,000 | $103.00 | $1,029,987.46 | -6.8% | - | - | |
| Mar 10, 2017 | CNMD Conmed Corp | President & CEO | Buy | 8,030 | $40.11 | $322,115.43 | +25.5% | - | - |